Skip to main content
. 2016 Feb 24;15:38. doi: 10.1186/s12933-016-0355-z

Table 2.

Demographic and other baseline characteristics of patients included in the cardiovascular meta-analysis—all randomized patients (ITT population)

Variable All comparators
(N = 2125)
All dulaglutide
(N = 3885)
Total
(N = 6010)
p valuea
Mean age (years) 56.0 56.2 56.1 0.78
Age group [n (%)] 0.30
 <65 years 1724 (81.1) 3177 (81.8) 4901 (81.6)
 ≥65 years 401 (18.9) 708 (18.2) 1109 (18.5)
Sex [n (%)] 0.27
 Female 1016 (47.8) 1916 (49.3) 2932 (48.8)
 Male 1109 (52.2) 1969 (50.7) 3078 (51.2)
Ethnicity [n (%)] 0.23
 Hispanic or Latino 660 (31.1) 1209 (31.1) 1869 (31.1)
 Not Hispanic or Latino 1463 (68.9) 2676 (68.9) 4139 (68.9)
Raceb [n (%)] 0.27
 American Indian or Alaska Native 135 (6.4) 231 (6.0) 366 (6.1)
 Asian 271 (12.8) 509 (13.1) 780 (13.0)
 Black or African American 113 (5.3) 245 (6.3) 358 (6.0)
 White 1446 (68.1) 2656 (68.4) 4102 (68.3)
Mean duration of diabetes (years) 8.0 7.9 7.9 0.22
Duration of diabetes 0.01
 <5 years 765 (36.0) 1494 (38.5) 2259 (37.6)
 ≥5 and <10 years 659 (31.0) 1088 (28.0) 1747 (29.1)
 ≥10 years 701 (33.0) 1303 (33.5) 2004 (33.3)
Mean BMI (kg/m2) 32.4 32.3 32.3 0.51
Fasting plasma glucose
 Mean (mmol/L) 9.07 9.01 9.04 0.69
 <5.6 mmol/L [n (%)] 109 (5.2) 200 (5.2) 309 (5.2) 0.79
 ≥5.6 mmol/L [n (%)] 1994 (94.8) 3630 (94.8) 5624 (94.8)
HbA1c
 Mean (%) 8.1 8.1 8.1 0.87
 Mean (mmol/mol) 65.0 65.0 65.0
 <8 % (<63.9 mmol/mol) [n (%)] 1113 (52.6) 2039 (52.6) 3152 (52.6) 0.62
 ≥8 % (≥63.9 mmol/mol) [n (%)] 1005 (47.5) 1838 (47.4) 2843 (47.4)

BMI body mass index, HbA1c glycosylated hemoglobin A1c

aCategorical variables were compared between treatments by Cochran–Mantel–Haenszel test. Continuous variables were compared between treatments by ANOVA model adjusting for strata: variable = treatment + stratum

bCategories omitted from the table: Native Hawaiian or Other Pacific Islander (0.1 % total), multiple (0.9 % total), and unknown (5.7 % total)